News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
38,205 Results
Type
Article (2436)
Company Profile (39)
Press Release (35730)
Multimedia
Podcasts (4)
Webinars (2)
Section
Business (14118)
Career Advice (77)
Deals (2076)
Drug Delivery (9)
Drug Development (4108)
Employer Resources (10)
FDA (436)
Job Trends (763)
News (20148)
Policy (1055)
Tag
2024 BioForest Digital (4)
2024 BioMidwest Digital (2)
2024 Biotech Bay Standard (2)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (1)
2025 Lone Star Bio Digital (1)
Academia (144)
Allergies (6)
Alliances (3472)
ALS (4)
Alzheimer's disease (46)
Antibody-drug conjugate (ADC) (14)
Approvals (437)
Artificial intelligence (10)
Autoimmune disease (3)
Automation (1)
Bankruptcy (11)
Best Places to Work (476)
BIOSECURE Act (2)
Biosimilars (12)
Biotechnology (29)
Bladder cancer (6)
Brain cancer (5)
Breast cancer (19)
Cancer (138)
Cardiovascular disease (4)
Career advice (64)
Career pathing (1)
CAR-T (15)
Cell therapy (43)
Cervical cancer (2)
Clinical research (3183)
Collaboration (92)
Compensation (47)
COVID-19 (180)
CRISPR (7)
C-suite (27)
Cystic fibrosis (2)
Data (112)
Denatured (3)
Depression (3)
Diabetes (10)
Diagnostics (464)
Digital health (1)
Diversity, equity & inclusion (1)
Drug discovery (15)
Drug pricing (7)
Duchenne muscular dystrophy (12)
Earnings (4235)
Editorial (3)
Employer branding (1)
Employer resources (8)
Events (6021)
Executive appointments (94)
FDA (482)
Featured Employer (3)
Funding (77)
Gene editing (14)
Gene therapy (18)
GLP-1 (60)
Government (150)
Healthcare (706)
Huntington's disease (3)
IgA nephropathy (3)
Immunology and inflammation (16)
Indications (2)
Infectious disease (185)
Inflammatory bowel disease (11)
Inflation Reduction Act (6)
Influenza (4)
Intellectual property (10)
Interviews (7)
IPO (987)
IRA (7)
Job creations (290)
Job search strategy (62)
Kidney cancer (4)
Labor market (3)
Layoffs (36)
Leadership (1)
Legal (212)
Liver cancer (5)
Lung cancer (15)
Lymphoma (3)
Management (4)
Manufacturing (18)
MASH (4)
Medical device (307)
Medtech (307)
Mergers & acquisitions (1157)
Metabolic disorders (34)
Multiple sclerosis (6)
Neurodegenerative disease (9)
Neuropsychiatric disorders (3)
Neuroscience (90)
NextGen: Class of 2025 (352)
Non-profit (153)
Northern California (356)
Now hiring (4)
Obesity (16)
Opinion (15)
Ovarian cancer (10)
Pain (9)
Pancreatic cancer (3)
Parkinson's disease (4)
Partnered (2)
Patents (22)
Patient recruitment (4)
Peanut (1)
People (5654)
Pharmaceutical (5)
Phase I (1373)
Phase II (1594)
Phase III (851)
Pipeline (73)
Policy (12)
Postmarket research (30)
Preclinical (592)
Press Release (2)
Prostate cancer (3)
Psychedelics (2)
Radiopharmaceuticals (12)
Rare diseases (21)
Real estate (420)
Recruiting (5)
Regulatory (805)
Reports (6)
Research institute (142)
Resumes & cover letters (9)
Schizophrenia (10)
Series A (25)
Series B (5)
Service/supplier (2)
Sickle cell disease (1)
Southern California (355)
Special edition (1)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (489)
Stomach cancer (1)
Supply chain (4)
The Weekly (1)
United States (1712)
Vaccines (28)
Venture capitalists (7)
Weight loss (12)
Women's health (1)
Worklife (1)
Date
Today (10)
Last 7 days (52)
Last 30 days (228)
Last 365 days (2559)
2025 (730)
2024 (2612)
2023 (2864)
2022 (3753)
2021 (4051)
2020 (3475)
2019 (2065)
2018 (1555)
2017 (1796)
2016 (1626)
2015 (1835)
2014 (1372)
2013 (1191)
2012 (1396)
2011 (1334)
2010 (1181)
Location
Africa (43)
Alabama (1)
Arizona (14)
Asia (1861)
Australia (298)
California (820)
Canada (132)
China (38)
Colorado (19)
Connecticut (10)
Delaware (4)
Europe (3817)
Florida (43)
Georgia (5)
Idaho (3)
Illinois (14)
India (1)
Indiana (32)
Japan (7)
Kansas (12)
Maryland (24)
Massachusetts (298)
Michigan (8)
Minnesota (14)
Missouri (3)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (68)
New York (47)
North Carolina (90)
Northern California (356)
Ohio (25)
Oklahoma (2)
Oregon (4)
Pennsylvania (48)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (355)
Tennessee (2)
Texas (70)
Utah (2)
Virginia (6)
Washington D.C. (1)
Washington State (50)
Wisconsin (6)
38,205 Results for "amador biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Amador Bioscience Welcomes Dr. Lorin Roskos as Chief Scientific Officer and President of Quantitative Clinical Pharmacology
Amador Bioscience has announced the appointment of Dr. Lorin Roskos as Chief Scientific Officer (CSO) and President of Quantitative Clinical Pharmacology (QCP).
May 5, 2023
·
2 min read
Business
Dr. Lorin K Roskos, Biopharmaceutical Leader and Executive, Joins Amador Bioscience’s Board of Directors
Amador Bioscience, a full-service CRO with global expertise in translational research and clinical development, announces the appointment of Lorin K Roskos, PhD, to its board of directors, effective immediately.
March 7, 2023
·
3 min read
Business
Amador Bioscience Appoints New Chief Technology Officer
Amador Bioscience, a global translational sciences and clinical pharmacology CRO, announced today that Dr. Meina Liang has joined the company as Chief Technology Officer.
January 7, 2022
·
2 min read
Biotech Bay
Amador Bioscience Announces the Completion of $60 Million Series B+ Round Financing
Amador Bioscience announced today that it has completed 60MM USD Series B+ financing led by MSA Capital, a global private equity firm .
December 30, 2021
·
5 min read
Deals
Amador Bioscience completed the acquisition of Ann Arbor Pharmacometrics Group (A2PG)
Amador Bioscience announced today that it has completed the acquisition of Ann Arbor Pharmacometrics Group ( A2PG), a premier pharmacometrics consulting firm based in Ann Arbor, Michigan.
December 24, 2021
·
3 min read
Biotech Bay
Translational Science Is the Key to the Success of the Clinical Research
In Q2 2023, Amador Bioscience, a next generation CRO focusing on translational science and early clinical development, announced the addition of Dr. Lorin Roskos to the Board of Directors.
December 5, 2023
·
11 min read
Layoffs
IGM Biosciences Lays Off 73% of Staff, Shrinks Pipeline
Staff cuts will leave IGM Biosciences with 37 employees. The company is also halting development of two bispecific antibody T cell engagers for autoimmune diseases.
January 10, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Harvard Bioscience Announces CFO Transition
April 11, 2025
·
3 min read
Press Releases
Chromatin Bioscience Signs Collaboration Agreement with Astellas
April 14, 2025
·
2 min read
Biotech Bay
Institutional Investors Co-Led Series B Financing of Amador Bioscience, a Global Translational Sciences and Clinical Pharmacology CRO
Amador Bioscience, a contract research organization that provides global-standard translational sciences and clinical pharmacology services to leading biopharmaceutical companies, announced the completion of Series B financing to support its further global expansion.
September 28, 2021
·
5 min read
1 of 3,821
Next
